HPMA copolymers: origins, early developments, present, and future

J Kopeček, P Kopečková - Advanced drug delivery reviews, 2010 - Elsevier
The overview covers the discovery of N-(2-hydroxypropyl) methacrylamide (HPMA)
copolymers, initial studies on their synthesis, evaluation of biological properties, and …

Immune system targeting by biodegradable nanoparticles for cancer vaccines

JM Silva, M Videira, R Gaspar, V Préat… - Journal of controlled …, 2013 - Elsevier
The concept of therapeutic cancer vaccines is based on the activation of the immune system
against tumor cells after the presentation of tumor antigens. Nanoparticles (NPs) have …

Polymer nanomedicines

J Kopeček, J Yang - Advanced drug delivery reviews, 2020 - Elsevier
Polymer nanomedicines (macromolecular therapeutics, polymer-drug conjugates, drug-free
macromolecular therapeutics) are a group of biologically active compounds that are …

Doxorubicin-loaded, charge reversible, folate modified HPMA copolymer conjugates for active cancer cell targeting

L Li, Q Yang, Z Zhou, J Zhong, Y Huang - Biomaterials, 2014 - Elsevier
Although folate exhibits many advantages over other targeting ligands, it has one major
defect: poor water solubility. Once it was conjugated to hydrophilic drug carrier such as N-(2 …

MDR in cancer: Addressing the underlying cellular alterations with the use of nanocarriers

MS Singh, SN Tammam, MAS Boushehri… - Pharmacological …, 2017 - Elsevier
Multidrug resistance (MDR) is associated with a wide range of pathological changes at
different cellular and intracellular levels. Nanoparticles (NPs) have been extensively …

Poly (2-methyl-2-oxazoline) conjugates with doxorubicin: From synthesis of high drug loading water-soluble constructs to in vitro anti-cancer properties

O Sedlacek, A Van Driessche, A Uvyn… - Journal of controlled …, 2020 - Elsevier
Abstract Poly (2-oxazoline) s represent an emerging class of polymers with increasing
potential in biomedical sciences. To date, most of the work on poly (2-oxazoline)-drug …

Nanoparticle-mediated drug delivery for treating melanoma

V Mundra, W Li, RI Mahato - Nanomedicine, 2015 - Future Medicine
Melanoma originated from melanocytes is the most aggressive type of skin cancer with
limited treatment options. New targeted therapeutic options with the discovery of BRAF and …

Impact of polymer-TLR-7/8 agonist (adjuvant) morphology on the potency and mechanism of CD8 T cell induction

GM Lynn, P Chytil, JR Francica, A Lagová… - …, 2019 - ACS Publications
Small molecule Toll-like receptor-7 and-8 agonists (TLR-7/8a) can be used as vaccine
adjuvants to induce CD8 T cell immunity but require formulations that prevent systemic …

Design of smart HPMA copolymer-based nanomedicines

J Yang, J Kopeček - Journal of Controlled Release, 2016 - Elsevier
The state-of-the art in water-soluble macromolecular therapeutics has been reviewed. First
the design principles for polymer-drug conjugates are discussed followed by two recent …

[HTML][HTML] Development of non-viral, trophoblast-specific gene delivery for placental therapy

N Abd Ellah, L Taylor, W Troja, K Owens, N Ayres… - PloS one, 2015 - journals.plos.org
Low birth weight is associated with both short term problems and the fetal programming of
adult onset diseases, including an increased risk of obesity, diabetes and cardiovascular …